News & Events about Vaxart Inc.
Mr. Lee brings almost 15 years of experience in strategy, M&A and partnering on more than $20 billion in transactions SOUTH SAN FRANCISCO, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc.(NASDAQ: VXRT) announced today that it has appointed Phillip Lee as its Chief Financial Officer (CFO), ...
Globe Newswire
2 months ago
Funding and support provided by Bill & Melinda Gates Foundation Study will focus on determining the ability of oral vaccine tablets to induce breast milk antibodies and transfer of antibodies to young infants SOUTH SAN FRANCISCO, Calif., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) ...
Globe Newswire
2 months ago
SOUTH SAN FRANCISCO, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, will present at the World Vaccine & Immunotherapy Congress West Coast 2022 in San Diego on Tuesday, November 29, 2022 at 1:50 p.m. PT...
Scott+Scott Attorneys at Law LLP and Hagens Berman Sobol Shapiro LLP Announce Pendency of Class Action To All Persons and Entities Who Purchased or Otherwise Acquired Shares of the Common Stock of Vaxart, Inc. During the Period Between June 15, 2020 and August 19, 2020, Inclusive Scott+Scott...
Globe Newswire
3 months ago
SOUTH SAN FRANCISCO, Calif., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James Cummings, Chief Medical Officer, will make separate presentations at the World Vaccine Congress Europe 2022 in ...